Abstract: A sensor apparatus is provided. Multiple opposite and self-powered sensors are provided in another aspect of the present apparatus. A further aspect employs a sensor apparatus including a first pair of flexible piezoelectric sensors attached to opposite sides of an exterior surface of a workpiece and at least a second pair of flexible piezoelectric sensors attached to opposite sides of the exterior surface of the workpiece. Another aspect of the present apparatus uses pairs of thin film piezoelectric sensors which are configured to detect bending curvature of a workpiece in at least two dimensions by sending voltage output signals from both of the sensors of a first pair and/or both of the sensors of at least a second pair to a controller and/or electrical circuit.
Type:
Grant
Filed:
November 16, 2021
Date of Patent:
June 4, 2024
Assignee:
Board of Trustees of Michigan State University
Inventors:
Yunqi Cao, Nelson Sepulveda-Alancastro, Henry D'Souza
Abstract: The current invention provides compositions, methods, and kits for detecting the exposure to and infection by certain viruses. Specifically, the current invention allows for the rapid differential serological detection of exposure to, and infection by viruses. In particular, the current invention allows for the rapid serological detection of exposure to, and infection by Zika virus (ZIKV).
Type:
Grant
Filed:
December 1, 2017
Date of Patent:
June 4, 2024
Assignee:
The Trustees of Columbia University in the City of New York
Inventors:
Walter Ian Lipkin, Nischay Mishra, Thomas Briese, Adrian Caciula
Abstract: Nanostraws and to methods of utilizing them in order to deliver biologically relevant molecules such as DNA, RNA, proteins etc., into non-adherent cells such as immune cells, embryos, plant cells, bacteria, yeast etc. The methods described herein are repeatedly capable of delivering biologically relevant cargo into non-adherent cells, with high cell viability, dosage control, unaffected proliferation or cellular development, and with high efficiency. Among other uses, these new delivery methods will allow to scale pre-clinical cell reprogramming techniques to clinical applications.
Type:
Grant
Filed:
October 27, 2020
Date of Patent:
June 4, 2024
Assignee:
The Board of Trustees of the Leland Stanford Junior University
Inventors:
Karl Martin Hjort, Sergio Leal-Ortiz, Yuhong Cao, Chris Rehse, Andy Kah Ping Tay, Nicholas A. Melosh
Abstract: Described herein are methods for lengthening tubular organs using expandable implants. The expandable implants may be secured along a length of a tubular organ by forming a plication at each end of the implant. Securing the expandable implants in this manner may be used to treat short bowel syndrome. Methods for selecting and implanting an expandable implant suitable for lengthening a tubular organ according to predetermined patient parameters are further described herein.
Type:
Grant
Filed:
May 14, 2021
Date of Patent:
June 4, 2024
Assignee:
The Board of Trustees of the Leland Stanford Junior University
Abstract: The present invention relates to the discovery that the expression levels of some microRNAs (miRNAs) can use a diagnostic signature to predict transplant outcomes in a transplant recipient. Thus, in various embodiments described herein, the methods of the invention relate to methods of diagnosing a transplant subject for acute rejection such as acute cellular rejection (ACR), methods of predicting a subject's risk of having or developing ACR and methods of assessing in a subject the likelihood of a successful or failure minimization of immunosuppression therapy (IST) dosage from standard ranges.
Type:
Grant
Filed:
March 26, 2019
Date of Patent:
June 4, 2024
Assignee:
The Trustees of the University of Pennsylvania
Inventors:
Abraham Shaked, Bao-Li Chang, Brendan Keating, Toumy Guettouche
Abstract: A passive thermal management system and methods of using a thermoresponsive hydrogel coating configured to autonomously switch between a heating state and a cooling state based on ambient temperature. At temperature greater than a lower critical solution temperature of the thermoresponsive hydrogel, the thermoresponsive hydrogel coating becomes solar reflective and has enhanced radiative cooling ability to achieve daytime radiative cooling. At temperatures less than the lower critical solution temperature, the thermoresponsive hydrogel coating becomes transparent to facilitate absorption of solar radiation by sun absorber.
Type:
Grant
Filed:
December 17, 2021
Date of Patent:
June 4, 2024
Assignees:
Toyota Motor Engineering & Manufacturing North America, Inc., The Board of Trustees of the University of Illinois
Inventors:
Shailesh N. Joshi, Dajie Xie, Paul Braun
Abstract: In an embodiment, the present disclosure pertains to a method of making magnetic nanoparticles through the utilization of a microfluidic reactor. In some embodiments, the microfluidic reactor includes a first inlet, a second inlet, and an outlet. In some embodiments, the method includes applying a magnetic nanoparticle precursor solution into the first inlet of the microfluidic reactor through a first flow rate and applying a reducing agent into the second inlet of the microfluidic reactor through a second flow rate. In some embodiments, the magnetic nanoparticles are produced in the microfluidic reactor and collected from the outlet of the microfluidic reactor. In an additional embodiment, the present disclosure pertains to a composition including a plurality of magnetic nanoparticles. In a further embodiment, the present disclosure pertains to a microfluidic reactor.
Type:
Grant
Filed:
April 20, 2020
Date of Patent:
June 4, 2024
Assignee:
Trustees of Dartmouth College
Inventors:
John X. J. Zhang, Nanjing Hao, Yuan Nie
Abstract: Compositions, methods, and kits are provided for treating bacterial infections with nanoparticles comprising a thiol-binding metallic core conjugated to a fluoroquinolone antibiotic. Recalcitrant infections are often difficult to treat because of the presence of persister cells, a subpopulation of bacterial cells that is highly tolerant of traditional antibiotics. Persister cells are dormant, which makes them less susceptible to many antibiotics, which are designed to kill growing cells. Administration of nanoparticles comprising a thiol-binding metallic core conjugated to fluoroquinolone antibiotics was found to be highly efficacious in eradicating persister cells and for treating infections for a broad range of bacterial species, including Gram-positive and Gram-negative bacteria. Such treatment was effective not only in eradicating planktonic bacteria but also bacteria in biofilms.
Type:
Grant
Filed:
April 13, 2022
Date of Patent:
June 4, 2024
Assignee:
The Board of Trustees of the Leland Stanford Junior University
Abstract: The present disclosure generally pertains to systems and methods for processing optical signals. In some embodiments, an optical system has an optical device for receiving a plurality of optical signals and processing such signals in a desired way. The optical device has one or more functional layers that are separated by buffer layers. The index of refraction of at various points in each functional layer is controlled during manufacturing so that the functional layer performs one or more optical functions or, in other words, manipulates one or more incoming optical signals in a desired way, such as switching, filtering, splitting, focusing, collimating, etc. As an example, the index of refraction profile within a region of a functional layer may be controlled so that an incoming signal from a first optical fiber is redirected for reception by a second optical fiber that is not aligned with the first optical fiber.
Type:
Grant
Filed:
August 13, 2020
Date of Patent:
June 4, 2024
Assignee:
The Board of Trustees of the University of Alabama, for and on behalf of the University of Alabama in Huntsville
Abstract: The present disclosure provides “all-in-one” cartridges which contain necessary reagents and materials to isolate/preconcentrate targeted proteins from blood plasma and ionize them for mass spectrometry detection. In another configuration, the cartridges include proteolytic enzymes to digest the proteins into smaller peptides in addition to preconcentration and ionization for mass spectrometry detection.
Type:
Grant
Filed:
April 11, 2019
Date of Patent:
June 4, 2024
Assignee:
The Trustees of Indiana University
Inventors:
Nicholas Edward Manicke, Chengsen Zhang
Abstract: Provided are compositions and methods for treating diseases associated with expression of mesothelin. Also provided are a chimeric antigen receptor (CAR) specific to mesothelin, vectors encoding the same, and recombinant T cells comprising the mesothelin CAR. Further provided are methods of administering a genetically modified T cell expressing a CAR that comprises a mesothelin binding domain.
Type:
Grant
Filed:
January 23, 2020
Date of Patent:
June 4, 2024
Assignees:
Novartis AG, The Trustees of the University of Pennsylvania
Inventors:
Gregory Beatty, Boris Engels, Neeraja Idamakanti, Carl H. June, Andreas Loew, Huijuan Song, Qilong Wu
Abstract: The present disclosure provides methods and compositions for treating RAG2 deficiencies in subjects, comprising genetically modifying cells from the subjects ex vivo by integrating a functional, codon-optimized RAG 2 cDNA at the endogenous RAG2 locus.
Type:
Application
Filed:
April 5, 2022
Publication date:
May 30, 2024
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Abstract: Provided herein are hydrogels that include a plurality of bacteriophages located within and covalently bonded to the hydrogel interior. The hydrogel is engineered to facilitate a controlled sustained release of the connected bacteriophages, e.g., to or within the body of a patient suffering from a bacterial infection. Also provided are methods for forming the provided hydrogels, and for using the hydrogels to treat a patient suffering from a bacterial infection.
Type:
Application
Filed:
March 25, 2022
Publication date:
May 30, 2024
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Inventors:
Ovijit CHAUDHURI, Paul L. BOLLYKY, Robert MANASHEROB, Yung-Hao LIN, Derek AMANATULLAH
Abstract: Processes and materials to detect cancer from a biopsy are described. In some cases, cell-free nucleic acids can be sequenced, and the sequencing result can be utilized to detect sequences derived from a neoplasm. Detection of somatic variants occurring in phase can indicate the presence of cancer in a diagnostic scan and a clinical intervention can be performed.
Type:
Application
Filed:
February 7, 2024
Publication date:
May 30, 2024
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Inventors:
David M. Kurtz, Maximilian Diehn, Arash Ash Alizadeh
Abstract: Systems and methods for compact and low-cost vibrational spectroscopy platforms are described. Many embodiments implement deep learning processes to identify the relevant optical spectral features for the identification of an element from a set of elements. Several embodiments provide that resolution reduction and feature selection render efficient data analysis processes. By reducing the spectral data from the full wide-band high-resolution spectrum to a subset of spectral bands, a number of embodiments provide compact and low-cost hardware incorporation in spectroscopic platforms for element identification functions.
Type:
Application
Filed:
March 30, 2022
Publication date:
May 30, 2024
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Inventors:
Jennifer A. Dionne, Ahmed Shuaibi, Amr A. E. Saleh
Abstract: The present disclosure provides modified immune cells (e.g., modified T cells) comprising a chimeric antigen receptor (CAR) having affinity for a prostate-specific membrane antigen (PSMA) (e.g., human PSMA). The present disclosure provides modified immune cells (e.g., modified T cells) comprising a CAR having affinity for PSMA and a dominant negative receptor and/or a switch receptor. The present disclosure provides modified immune cells (e.g., modified T cells) comprising a CAR having affinity for PSMA and a dominant negative receptor and/or a switch receptor, wherein the modified cell is capable of expressing and secreting a bispecific antibody.
Type:
Grant
Filed:
July 20, 2020
Date of Patent:
May 28, 2024
Assignee:
The Trustees of the University of Pennsylvania
Abstract: Disclosed are devices, methods, systems, media, and other implementations that include a method comprising accessing during execution of a process a memory element, determining whether data stored in the accessed memory element includes security data representative of locations that, if accessed, indicate a potential system violation condition, determining, in response to a determination that the accessed memory element includes the security data, whether execution of the process involves access of one or more memory locations in the accessed memory element containing the security data, and performing one or more remedial actions in response to a determination that the one or more memory locations in the memory element containing the security data are being accessed.
Type:
Grant
Filed:
January 16, 2020
Date of Patent:
May 28, 2024
Assignee:
The Trustees of Columbia University in the City of New York
Inventors:
Lakshminarasimhan Sethumadhavan, Hiroshi Sasaki, Mohamed Tarek Bnziad Mohamed Hassan, Miguel A. Arroyo
Abstract: Silicon carbide on insulator is provided by bonding bulk silicon carbide to a substrate with an oxide-oxide fusion bond, followed by thinning the bulk silicon carbide as needed. A doping-selective etch for silicon carbide is used to improve thickness uniformity of the silicon carbide layer(s).
Type:
Grant
Filed:
September 3, 2021
Date of Patent:
May 28, 2024
Assignee:
The Board of Trustees of the Leland Stanford Junior University
Abstract: The present invention features nucleic acid trans-splicing molecules (e.g., pre-mRNA trans-splicing molecules (RTMs)) capable of correcting one or more mutations in the ABCA4 gene or the CEP290 gene. Such molecules are useful in the treatment of disorders associated with mutations in ABCA4, such as Stargardt Disease (e.g., Stargardt Disease 1) and disorders associated with a mutation in CEP290, such as Leber congenital amourosis 10 (LCA 10). Also provided by the invention described herein are methods of using the nucleic acid trans-splicing molecules for correcting mutations in ABCA4 and CEP290 and for treating disorders associated with mutations in ABCA4 and CEP290, such as Stargardt Disease and LCA 10.
Type:
Grant
Filed:
April 17, 2019
Date of Patent:
May 28, 2024
Assignees:
Ascidian Therapeutics, Inc., The Trustees of the University of Pennsylvania
Inventors:
Philip R. Johnson, Bruce C. Schnepp, Jean Bennett, Scott J. Dooley, Krishna Jawaharlal Fisher, Junwei Sun
Abstract: Provided are systems and methods for analyzing medical images to localize body regions using deep learning techniques. A combination of convolutional neural network (CNN) and a recurrent neural network (RNN) can be applied to medical images, identifying axial slices of a body region. In accordance with embodiments, boundaries, e.g., superior and inferior boundaries of various body regions in computed tomography images can be automatically demarcated.
Type:
Grant
Filed:
February 10, 2021
Date of Patent:
May 28, 2024
Assignee:
The Trustees of the University of Pennsylvania
Inventors:
Jayaram K. Udupa, Vibhu Agrawal, Yubing Tong, Drew A. Torigian